-
May 11, 2021 DMT-Focused Psychedelic Company Small Pharma Launches on TSX Venture ExchangeDMT-focused psychedelic therapy company Small Pharma is listing on the Canadian TSK Venture Exchange as...
-
May 7, 2021 Psychedelic Business News Spotlight: May 7, 2021This week in psychedelic business news: LSD for pain, DMT and organ transplants, Champignon Brands...
-
April 14, 2021 GH Research Raises $125 Million to Fund DMT Treatment for DepressionGH Research closed a $125 million Series B financing round to fund the advancement of...
-
March 15, 2021 Small Pharma Clinical Trials to Study DMT for Treatment-Resistant DepressionSmall Pharma is going into clinical trials to look at DMT for depression relief. The...
-
March 11, 2021 Algernon to Investigate DMT Microdose for Stroke TreatmentAlgernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential...
-
March 10, 2021 Core One Labs and Ketamine Infusion Centers to Explore DMT Therapy for Anxiety and DepressionCore One Labs is exploring DMT therapy for anxiety and depression in a partnership with...
